Insulin resistance is being increasingly reported in type-1 Diabetes (T1D) and is known to accelerate microvascular complications. The Asian Indian population has a higher risk of double diabetes deve
MTF116086 is an open-label, randomised, parallel-design study in subjects with type II diabetes. The study is site-based, with local pharmacies serving as the sites and pharmacists as principal invest
Background: This meta-analysis aimed to combine the data available from clinical trials to assess the effects of subcutaneous and oral semaglutide administration on glycemic control, weight management
The data are presented as the means (SD) or n (%).*HbGroup 1; glimepiride 1 mg, gliclazide 80 mg, gliclazide MR 30 mg, glibenclamide 5 mg, Group 2; glimepiride 2 mg, gliclazide 160 mg, gliclazide MR 6
